EP Patent

EP4596561A1 — Phosphorus-containing compound, pharmaceutical composition and use thereof

Assigned to Suzhou Genhouse Bio Co Ltd · Expires 2025-08-06 · 1y expired

What this patent protects

Provided in the present invention are a phosphorus-containing compound, a pharmaceutical composition and the use thereof. Specifically, provided are a compound as represented by formula I, a pharmaceutically acceptable salt, an ester, a stereoisomer, a tautomer, a polymorph, a so…

USPTO Abstract

Provided in the present invention are a phosphorus-containing compound, a pharmaceutical composition and the use thereof. Specifically, provided are a compound as represented by formula I, a pharmaceutically acceptable salt, an ester, a stereoisomer, a tautomer, a polymorph, a solvate, a metabolite, an isotopic derivative or a prodrug thereof. The phosphorus-containing compound of the present invention can effectively treat diseases and conditions mediated by TEAD, such as cancer.

Drugs covered by this patent

Patent Metadata

Patent number
EP4596561A1
Jurisdiction
EP
Classification
—
Expires
2025-08-06
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Genhouse Bio Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.